Live from the NIH registry
Studies recruiting near Ogden right now
Top 25 of 115 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10305, Layton, UT — Layton, Utah (11.6 mi)
· Sponsor: Colorado Prevention Center
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
Respiration, Artificial
N/A
Interventional 13,400 participants sought
Mckay Dee Hospital — Ogden, Utah (0.4 mi)
· Sponsor: Intermountain Health Care, Inc.
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
Care Access-Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Eli Lilly and Company
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7085 — Bountiful, Utah (23.8 mi)
· Sponsor: Galderma R&D
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Advanced Research Institute — Ogden, Utah (0.4 mi)
· Sponsor: Kallyope Inc.
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Psoriasis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Tanner Clinic — Layton, Utah (11.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Alpine Research Organization - Clinton /ID# 276497 — Clinton, Utah (7.4 mi)
· Sponsor: AbbVie
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Advanced Research Institute - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: vTv Therapeutics
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
Schizophrenia, Autism-Related Irritability
Phase 3
Interventional 400 participants sought
Local Institution - 0167 — West Point, Utah (9.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 150 participants sought
Community Cancer Trials Of Utah /ID# 276598 — Ogden, Utah (0.4 mi)
· Sponsor: AbbVie
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 220 participants sought
START Mountain — Ogden, Utah (0.4 mi)
· Sponsor: Vividion Therapeutics, Inc.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Ogden Regional Cancer Center — Ogden, Utah (0.4 mi)
· Sponsor: Agendia
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Phase 3
Interventional 1,000 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL)
Phase 3
Interventional 904 participants sought
Community Cancer Trials of Utah — Ogden, Utah (0.4 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400016 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: NRG Oncology
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: NRG Oncology
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Eli Lilly and Company
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Pleasant View, Utah (6.4 mi)
· Sponsor: Kailera
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12153 — South Ogden, Utah (2.5 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 750 participants sought
GSK Investigational Site — Roy, Utah (5.5 mi)
· Sponsor: GlaxoSmithKline
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 990 participants sought
Research Site — Clearfield, Utah (8.6 mi)
· Sponsor: AstraZeneca
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400007 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Pneumococcal Immunization, Healthy Volunteers
Phase 3
Interventional 2,195 participants sought
Rio Clinical Trials - Canyon View- Site Number : 8400031 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
Community Cancer Trials of Utah - South Ogden /ID# 262829 — Ogden, Utah (0.4 mi)
· Sponsor: AbbVie